Regeneron Pharmaceuticals Inc. (REGN) — Insider Trading

Sector: Healthcare â€ĸ All Insider Transactions

🔄 Last update: 11/17/2026 at 14:20 UTC
Sales (90d)
$51.9M
60 transactions
Buys (90d)
$0
0 transactions
WhaleSentiment Score â„šī¸
🔴 -64
Allarme
Form 144 Filings
10
Upcoming sale notices
Cluster Sell

Stock Price REGN 📉

REGN stock price — last 6 months

Last Price
$952.40
16/11/2026 (market close)
Daily Change
-3.07 (-0.32%)
6-Month Performance
+51.7%
$628.01 → $952.40
6M High / 6M Low
$973.36
Min: $599.96
$600$693$787$880$973 2026-05-182026-08-182026-11-16 SELL 2026-11-04SELL 2026-11-03SELL 2026-11-02SELL 2026-10-30SELL 2026-10-14SELL 2026-09-03SELL 2026-09-02Insider Sell (60)

▲ = insider buy (0), â–ŧ = insider sell (60)

Data from Yahoo Finance, 15-min delay. Last update: 16/11/2026 (market close).

All Insider Transactions REGN — 2026

Insider Transactions

Date Insider Role Type Shares Price Value
11/04/2026 Pitofsky Jason SVP Controller Exercise 1,500 $726.53 $1.1M
11/04/2026 Pitofsky Jason SVP Controller Exercise 1,478 $644.54 $1.0M
11/04/2026 Pitofsky Jason SVP Controller Exercise 905 $492.00 $0.4M
11/04/2026 Pitofsky Jason SVP Controller Sale 439 $939.57 $0.4M
11/04/2026 Pitofsky Jason SVP Controller Sale 575 $940.46 $0.5M
11/04/2026 Pitofsky Jason SVP Controller Sale 982 $941.58 $0.9M
11/04/2026 Pitofsky Jason SVP Controller Sale 1,215 $942.31 $1.1M
11/04/2026 Pitofsky Jason SVP Controller Sale 529 $943.53 $0.5M
11/04/2026 Pitofsky Jason SVP Controller Sale 108 $944.22 $0.1M
11/04/2026 Pitofsky Jason SVP Controller Sale 35 $945.61 $0.03M
11/04/2026 Pitofsky Jason SVP Controller Sale 179 $950.76 $0.2M
11/04/2026 Pitofsky Jason SVP Controller Exercise 905 — —
11/04/2026 Pitofsky Jason SVP Controller Exercise 1,478 — —
11/04/2026 Pitofsky Jason SVP Controller Exercise 1,500 — —
11/03/2026 MURPHY ANDREW J Co-Chief Scientific Officer Gift 1,054 — —
11/03/2026 Zoghbi Huda Y Director Exercise 7,439 $380.95 $2.8M
11/03/2026 Zoghbi Huda Y Director Sale 6,939 $970.42 $6.7M
11/03/2026 Zoghbi Huda Y Director Sale 500 $971.06 $0.5M
11/03/2026 Zoghbi Huda Y Director Exercise 7,439 — —
11/02/2026 SING GEORGE L Director Exercise 7,830 $376.69 $2.9M
11/02/2026 SING GEORGE L Director Exercise 7,439 $380.95 $2.8M
11/02/2026 SING GEORGE L Director Sale 1,224 $960.57 $1.2M
11/02/2026 SING GEORGE L Director Sale 540 $961.85 $0.5M
11/02/2026 SING GEORGE L Director Sale 2,522 $962.61 $2.4M
11/02/2026 SING GEORGE L Director Sale 4,338 $963.47 $4.2M
11/02/2026 SING GEORGE L Director Sale 2,670 $964.57 $2.6M
11/02/2026 SING GEORGE L Director Sale 7,073 $965.38 $6.8M
11/02/2026 SING GEORGE L Director Sale 1,522 $966.27 $1.5M
11/02/2026 SING GEORGE L Director Sale 1,040 $967.07 $1.0M
11/02/2026 SING GEORGE L Director Sale 200 $970.18 $0.2M
11/02/2026 SING GEORGE L Director Exercise 7,830 — —
11/02/2026 SING GEORGE L Director Exercise 7,439 — —
11/02/2026 POON CHRISTINE A Director Exercise 7,830 $376.69 $2.9M
11/02/2026 POON CHRISTINE A Director Sale 218 $966.74 $0.2M
11/02/2026 POON CHRISTINE A Director Sale 772 $967.38 $0.7M
11/02/2026 POON CHRISTINE A Director Sale 2,499 $968.58 $2.4M
11/02/2026 POON CHRISTINE A Director Sale 3,203 $969.50 $3.1M
11/02/2026 POON CHRISTINE A Director Sale 937 $970.51 $0.9M
11/02/2026 POON CHRISTINE A Director Sale 201 $971.31 $0.2M
11/02/2026 POON CHRISTINE A Director Exercise 7,830 — —
11/02/2026 Fenimore Christopher R. EVP Finance CFO Exercise 6,000 $381.92 $2.3M
11/02/2026 Fenimore Christopher R. EVP Finance CFO Tax 4,243 $950.50 $4.0M
11/02/2026 Fenimore Christopher R. EVP Finance CFO Gift 15 — —
11/02/2026 Fenimore Christopher R. EVP Finance CFO Exercise 6,000 — —
11/02/2026 LAROSA JOSEPH J EVP General Counsel and Secret Exercise 12,283 $381.92 $4.7M
11/02/2026 LAROSA JOSEPH J EVP General Counsel and Secret Tax 8,686 $950.50 $8.3M
11/02/2026 LAROSA JOSEPH J EVP General Counsel and Secret Sale 3,939 $965.41 $3.8M
11/02/2026 LAROSA JOSEPH J EVP General Counsel and Secret Sale 527 $966.11 $0.5M
11/02/2026 LAROSA JOSEPH J EVP General Counsel and Secret Exercise 12,283 — —
10/30/2026 Guarini Kathryn Director Exercise 400 $719.37 $0.3M

Holdings Summary

InsiderRoleShares HeldLast Transaction
LAROSA JOSEPH J EVP General Counsel and Secret 52,058 11/02/2026
MURPHY ANDREW J Co-Chief Scientific Officer 46,779 11/03/2026
SING GEORGE L Director 38,837 11/02/2026
Fenimore Christopher R. EVP Finance CFO 25,984 11/02/2026
POON CHRISTINE A Director 13,049 11/02/2026
McCourt Marion EVP Commercial 10,871 10/30/2026
Zoghbi Huda Y Director 9,142 11/03/2026
Pitofsky Jason SVP Controller 5,772 11/04/2026
BROWN MICHAEL S Director 3,309 10/30/2026
Guarini Kathryn Director 1,003 10/30/2026

âš ī¸ Form 144 — Upcoming Sale Notices

Form 144 is filed BEFORE the actual sale. It is an important leading indicator.

Filing DateTypeSEC Link
11/16/2026 144 View Filing →
11/16/2026 144 View Filing →
11/04/2026 144 View Filing →
11/04/2026 144 View Filing →
11/03/2026 144 View Filing →
11/02/2026 144 View Filing →
11/02/2026 144 View Filing →
11/02/2026 144 View Filing →
10/30/2026 144 View Filing →
10/30/2026 144 View Filing →

Financial Context

Recent financial data from SEC filings (XBRL) to contextualize insider activity.

Revenue (latest quarter)
$1511M
Period: 2018-03-31
Net Income
$1949M
Profit
Diluted EPS
$18.45
Per share

What is Insider Trading on Regeneron Pharmaceuticals Inc.?

Legal insider trading occurs when executives, directors, and major shareholders (>10%) of a public company buy or sell shares of their own company and report it to the SEC via Form 4.

How to Read the Data

Open market purchases (P) — the strongest signal. The insider uses their own money to buy shares.

Signals to Watch for REGN

Sources & References

All data on this page comes directly from public SEC filings.

📋 View all Form 4 filings on SEC EDGAR REGN →

Insider Trading — Healthcare Sector

Other Healthcare stocks with monitored insider activity:

đŸ”Ĩ Most Active Stocks — Insider Trading

Stocks with the highest number of recent insider transactions:

📚 Related Resources

âš ī¸ Disclaimer: WhaleSentiment provides public SEC data for informational and educational purposes only. It does not provide financial advice, investment recommendations, or solicitation to buy/sell financial instruments. Always consult a qualified financial advisor before making investment decisions.